NovoCure GmbH   Report issue

For profit Phase 2
Founded: Munich Germany (2000)

Organization Overview

First Clinical Trial
2019
NCT04281576
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

NovoCure GmbH

Indications

Overview

  • Highest Phase: Phase 2
  • # of Trials: 3
  • # of Trial APIs: 6